JP2005504789A5 - - Google Patents

Download PDF

Info

Publication number
JP2005504789A5
JP2005504789A5 JP2003526403A JP2003526403A JP2005504789A5 JP 2005504789 A5 JP2005504789 A5 JP 2005504789A5 JP 2003526403 A JP2003526403 A JP 2003526403A JP 2003526403 A JP2003526403 A JP 2003526403A JP 2005504789 A5 JP2005504789 A5 JP 2005504789A5
Authority
JP
Japan
Prior art keywords
substituted
group
alkyl
unsubstituted
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003526403A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005504789A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/027514 external-priority patent/WO2003022274A2/en
Publication of JP2005504789A publication Critical patent/JP2005504789A/ja
Publication of JP2005504789A5 publication Critical patent/JP2005504789A5/ja
Pending legal-status Critical Current

Links

JP2003526403A 2001-09-13 2002-08-28 癌治療のための２−アロイルイミダゾール化合物 Pending JP2005504789A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32210501P 2001-09-13 2001-09-13
PCT/US2002/027514 WO2003022274A2 (en) 2001-09-13 2002-08-28 2-aroylimidazole compounds for treating cancer

Publications (2)

Publication Number Publication Date
JP2005504789A JP2005504789A (ja) 2005-02-17
JP2005504789A5 true JP2005504789A5 (cg-RX-API-DMAC7.html) 2006-01-05

Family

ID=23253436

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003526403A Pending JP2005504789A (ja) 2001-09-13 2002-08-28 癌治療のための２−アロイルイミダゾール化合物

Country Status (6)

Country Link
US (2) US6743919B2 (cg-RX-API-DMAC7.html)
EP (1) EP1427413A2 (cg-RX-API-DMAC7.html)
JP (1) JP2005504789A (cg-RX-API-DMAC7.html)
AU (1) AU2002323475B2 (cg-RX-API-DMAC7.html)
CA (1) CA2460345A1 (cg-RX-API-DMAC7.html)
WO (1) WO2003022274A2 (cg-RX-API-DMAC7.html)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005504789A (ja) * 2001-09-13 2005-02-17 シンタ ファーマスーティカルズ コーポレイション 癌治療のための２−アロイルイミダゾール化合物
DE60320766D1 (de) * 2002-02-12 2008-06-19 Wisconsin Alumni Res Found Synthese von indolthiazolverbindungen als liganden des ah-rezeptors
TW200503738A (en) * 2003-07-16 2005-02-01 Tzu Chi Buddhist General Hospital Method for extracting antineoplastic components from bupleurum scorzonerifolium
EP1697352B1 (en) 2003-09-24 2012-06-27 Vertex Pharmceuticals Incorporated 4-azole substituted imidazole compositions useful as inhibitors or c-met receptor tyrosine kinase
BRPI0416085A (pt) * 2003-10-31 2007-01-02 Auckland Uniservices Ltd álcoois de nitrofenil mostarda e nitrofenilaziridina e seus fosfatos correspondentes e seu uso como agentes citotóxicos alvo-dirigidos
GB0403781D0 (en) * 2004-02-20 2004-03-24 Astrazeneca Ab Chemical compounds
MX2007003332A (es) 2004-09-20 2007-06-05 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como inhibidores de estearoil-coa-desaturasa.
BRPI0515482A (pt) 2004-09-20 2008-07-22 Xenon Pharmaceuticals Inc derivados heterocìclicos e seus usos como agentes terapêuticos
AR051092A1 (es) 2004-09-20 2006-12-20 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como inhibidores de la estearoil-coa
TW200626155A (en) 2004-09-20 2006-08-01 Xenon Pharmaceuticals Inc Heterocyclic derivatives and their use as therapeutic agents
EP2289510A1 (en) 2004-09-20 2011-03-02 Xenon Pharmaceuticals Inc. Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
JP5043668B2 (ja) 2004-09-20 2012-10-10 ゼノン・ファーマシューティカルズ・インコーポレイテッド 複素環誘導体および治療薬としてのそれらの使用
CN101084212A (zh) 2004-09-20 2007-12-05 泽农医药公司 杂环衍生物及其作为硬脂酰CoA去饱和酶介导剂的用途
WO2006128129A2 (en) * 2005-05-26 2006-11-30 Synta Pharmaceuticals Corp. Method for treating cancer
JP2009513563A (ja) 2005-06-03 2009-04-02 ゼノン・ファーマシューティカルズ・インコーポレイテッド ヒトのステアロイル−ＣｏＡデサチュラーゼ阻害剤としてのアミノチアゾール誘導体
US20100256046A1 (en) * 2009-04-03 2010-10-07 Tetralogic Pharmaceuticals Corporation Treatment of proliferative disorders
WO2007021825A2 (en) * 2005-08-09 2007-02-22 Tetralogic Pharmaceuticals Corporation Treatment of proliferative disorders
US8883841B2 (en) * 2005-11-23 2014-11-11 The Board Of Regents Of The University Of Texas System Oncogenic ras-specific cytotoxic compound and methods of use thereof
WO2007070892A2 (en) * 2005-12-16 2007-06-21 Ironwood Pharmaceuticals, Inc. Useful indole compounds
US7649098B2 (en) * 2006-02-24 2010-01-19 Lexicon Pharmaceuticals, Inc. Imidazole-based compounds, compositions comprising them and methods of their use
WO2008005908A2 (en) 2006-07-07 2008-01-10 Forest Laboratories Holdings Limited Pyridoimidazole derivatives
WO2008085302A1 (en) * 2006-12-20 2008-07-17 Merck & Co., Inc. Imidazopyridine analogs as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseases
TW200920355A (en) * 2007-09-06 2009-05-16 Lexicon Pharmaceuticals Inc Compositions and methods for treating immunological and inflammatory diseases and disorders
JP5638955B2 (ja) * 2007-10-26 2014-12-10 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ Ｐｉ３キナーゼ阻害剤として有用なプリン誘導体
CN102105474B (zh) 2008-05-30 2014-01-08 健泰科生物技术公司 嘌呤pi3k抑制剂化合物及使用方法
US8513221B2 (en) 2008-07-07 2013-08-20 Xcovery Holding, LLC PI3K isoform selective inhibitors
MX2011012520A (es) 2009-05-27 2011-12-12 Hoffmann La Roche Compuestos inhibidores de pi3k de pirimidina biciclicos selectivos para p110 delta y metodos de uso de los mismos.
EP2560640A1 (en) 2010-04-19 2013-02-27 Synta Pharmaceuticals Corp. Cancer therapy using a combination of a hsp90 inhibitory compounds and a egfr inhibitor
JP5555378B2 (ja) 2010-07-14 2014-07-23 エフ．ホフマン−ラ ロシュ アーゲー Ｐｉ３ｋｐ１１０デルタに選択的なプリン化合物とその使用の方法
ES2646834T3 (es) 2010-08-20 2017-12-18 Amira Pharmaceuticals, Inc. Inhibidores de autotaxina y usos de los mismos
JP5775171B2 (ja) 2010-12-16 2015-09-09 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト 三環系ｐｉ３ｋ阻害剤化合物及びその使用方法
US9260416B2 (en) 2011-05-27 2016-02-16 Amira Pharmaceuticals, Inc. Heterocyclic autotaxin inhibitors and uses thereof
JP2014534228A (ja) 2011-11-02 2014-12-18 シンタ ファーマシューティカルズ コーポレーション 白金含有剤とｈｓｐ９０阻害剤の組合せ療法
US9439899B2 (en) 2011-11-02 2016-09-13 Synta Pharmaceuticals Corp. Cancer therapy using a combination of HSP90 inhibitors with topoisomerase I inhibitors
EP2780010A1 (en) 2011-11-14 2014-09-24 Synta Pharmaceuticals Corp. Combination therapy of hsp90 inhibitors with braf inhibitors
CN108841778B (zh) * 2018-04-28 2022-05-17 大连普瑞康生物技术有限公司 一种红豆杉细胞组织培养物
US12404265B2 (en) 2020-08-04 2025-09-02 Nura Bio, Inc. Substituted pyridine derivatives as SARM1 inhibitors
CN116438171A (zh) 2020-09-16 2023-07-14 努拉生物公司 作为sarm1抑制剂的取代的吡啶衍生物
CA3226869A1 (en) 2021-07-28 2023-02-02 Rao Kolluri Substituted pyridine derivatives as sarm1 inhibitors
WO2023064486A1 (en) * 2021-10-14 2023-04-20 Galileo Biosystems, Inc. Aryl hydrocarbon receptor (ahr) modulators and therapeutic uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0272810A3 (en) * 1986-11-26 1988-07-20 Harbor Branch Oceanographic Institution, Inc. Antitumor and antiviral alkaloids
US4866084A (en) * 1987-07-17 1989-09-12 Harbor Branch Oceanographic Institution, Inc. Topsentin compounds effective against viruses and certain tumors
US5290777A (en) 1993-02-24 1994-03-01 Regents Of The Univ. Of California Use for topsentin compounds and pharmaceutical compositions containing same
NZ321172A (en) * 1995-10-03 2000-02-28 Scripps Research Inst CBI analogs of CC-1065 and the duocarmycins
DE69727305T2 (de) 1996-10-31 2004-06-24 Harbor Branch Oceanographic Institution, Inc., Fort Pierce Verwendung neurogen-entzuendungshemmender verbindungen und zusammensetzungen
WO1999042092A2 (en) 1998-02-20 1999-08-26 Harbor Branch Oceanographic Institution, Inc. Compounds and methods of use for treatment of neurogenic inflammation
WO2000002857A1 (en) 1998-07-08 2000-01-20 Harbor Branch Oceanographic Institution, Inc. Bis-indole derivatives and their use as antiinflammatory agents
SK16482001A3 (sk) * 1999-05-21 2002-04-04 Scios Inc. Indolové deriváty ako inhibítory p38 kinázy
JP2005504789A (ja) 2001-09-13 2005-02-17 シンタ ファーマスーティカルズ コーポレイション 癌治療のための２−アロイルイミダゾール化合物

Similar Documents

Publication Publication Date Title
JP2005504789A5 (cg-RX-API-DMAC7.html)
ES2352555T3 (es) Derivados de 5-(benc-(z)-iliden)tiazolidin-4-ona como agentes inmunosupresores.
ES2333445T3 (es) Derivados del acido 2-fenilpropionico y composiciones farmaceuticas que los contienen.
ES2401281T3 (es) Derivados de piperidil-2,6-diona usados para inhibir la liberación del factor de necrosis tumoral de las células
TW536539B (en) Novel substituted imidazole compounds
RU2008136187A (ru) Новое производное кумарина, обладающее противоопухолевой активностью
RU2017121906A (ru) Конъюгаты цистеамина и жирной кислоты и их применение в качестве активаторов аутофагии
JP2007504160A5 (cg-RX-API-DMAC7.html)
JP2001526220A5 (cg-RX-API-DMAC7.html)
JP2007504284A5 (cg-RX-API-DMAC7.html)
US8653276B2 (en) 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation thereof and therapeutic application thereof as urotensin II receptor antagonists
JP2007528417A5 (cg-RX-API-DMAC7.html)
JP2004509113A5 (cg-RX-API-DMAC7.html)
RU2006109108A (ru) Соединения, обладающие активностью антагонистов crth2 рецепторов
BG64507B1 (bg) Производни на карбамида като инхибитори на ензим инозин-5'-монофосфат дехидрогеназа
RU2003133448A (ru) 3,4-дизамещенные циклобутен-1,2-дионы как лиганды схс- хемокинового рецептора
JP2007532651A5 (cg-RX-API-DMAC7.html)
RU2005119633A (ru) Антивирусные нуклеозидные производные
RU2012118667A (ru) Гетероциклические соединения, используемые в качестве ингибиторов pdk1
JP2006508970A5 (cg-RX-API-DMAC7.html)
KR20120055571A (ko) 종양성 또는 자가면역 질환 치료용 전구약물로서의 푸라자노벤즈이미다졸
JPWO2019126691A5 (cg-RX-API-DMAC7.html)
JP2006507355A5 (cg-RX-API-DMAC7.html)
RU2007118687A (ru) Триазолы, используемые в качестве ингибиторов протеинкиназ
JP2005504795A5 (cg-RX-API-DMAC7.html)